Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Centipede Envenomation : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
[Snake Envenomations, Mojave Rattle]

Abdominal Pain in Elderly Persons

Anaphylaxis

Bee and Hymenoptera Stings

Bites, Insects

Caterpillar Envenomations

Cellulitis

Snake Envenomations, Brown

Snake Envenomations, Cobra

Snake Envenomations, Coral

Snake Envenomations, Moccasins

Snake Envenomations, Rattle

Snake Envenomations, Sea

Spider Envenomations, Brown Recluse

Spider Envenomations, Funnel Web

Spider Envenomations, Redback

Spider Envenomations, Tarantula

Spider Envenomations, Widow




Patient Education
Click here for patient education.



Author: Robert Norris, MD, Chief, Associate Professor, Department of Surgery, Division of Emergency Medicine, Stanford University Medical Center

Robert Norris is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, and Wilderness Medical Society

Editors: Debra Slapper, MD, Consulting Staff, Department of Emergency Medicine, St Anthony's Hospital; John T VanDeVoort, PharmD, ABAT, Director of Pharmacy, Sacred Heart Hospital; Gino A Farina, MD, Program Director, Associate Professor of Clinical Emergency Medicine, Department of Emergency Medicine, Long Island Jewish Medical Center, Albert Einstein College of Medicine; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Scott H Plantz, MD, FAAEM, Associate Professor, Research Director, Department of Emergency Medicine, Mount Sinai School of Medicine

Author and Editor Disclosure

Synonyms and related keywords: centipede envenomations, centipede sting, Scolopendra species, Scolopendra, Scolopendra gigantea, Scolopendra heros, Scolopendra subspinipes, Otostigmus species, Otostigmus, Chilopoda, Arthropoda, centipede venom

Background

Approximately 3000 species of centipedes are found in the class Chilopoda, phylum Arthropoda. They are among the less well-studied arthropods. Centipedes are elongated multisegmented arthropods with a single pair of legs on each body segment. They are distributed widely, especially in warm, temperate, and tropical regions. Centipedes spend much of their time underground or in rock piles and usually come out at night to actively hunt their prey. They are capable of very fast movement when exposed. The most dangerous species belong to the genus Scolopendra, with the largest members (Scolopendra gigantea) reaching lengths of 26 cm.

Pathophysiology

The venom delivery apparatus consists of a modified pair of front legs (ie, forcipules) just behind the mandibles. Venom is produced in a gland at the base of the forcipules and is injected through ducts when the forcipules are driven into the victim's tissues. The venoms have not been studied extensively but, at least in some species, contain 5-hydroxytryptamine, hemolytic phospholipase A, and a cardiotoxic protein. The venom of the North American giant desert centipede, Scolopendra heros, contains a cytolysin. Most likely, other important components are present in these venoms, which require further study. In addition to venom, some species exude defensive substances from glands found along the body segments. These secretions are usually nontoxic to humans, although at least one species of the genus Otostigmus secretes a vesicating substance.

Mortality/Morbidity

Most species are relatively innocuous.

  • Fatalities are extremely rare following scorpion stings. A death was reported in a 7-year-old Filipino girl who was stung on the head by a centipede of the large species Scolopendra subspinipes, which may reach 23 cm in length.
  • A case of electrocardiographic (ECG) changes suggestive of ischemia has been reported in a 60-year-old man after a sting by a 12-cm centipede in Turkey. While there was a slight associated elevation in serum CK-MB and myoglobin, troponin I, troponin T, and delayed exercise stress testing were all normal, and the ECG returned to normal a few hours later. Another 20-year-old man in Turkey presented to an ED with chest pain approximately 24 hours after a reported centipede sting. His ECG revealed inferior ST segment elevation, and he had a positive rise in his CK-MB and troponin T levels. His echocardiogram was normal, and he did well after conservative therapy (without thrombolysis or angioplasty). Delayed coronary angiography revealed normal coronary arteries. The patient was noted to be "completely symptom free" at 17 months. He was felt to have suffered a myocardial infarction, possibly related to coronary vasospasm, inflammatory changes, or multifactorial effects.
  • A case of rhabdomyolysis complicated by compartment syndrome and acute renal failure requiring temporary hemodialysis has been reported following the sting of the giant desert centipede, Scolopendra heros. Prolonged, isolated proteinuria without any other evidence of renal dysfunction has also been reported in a young female following Scolopendra sting.



History

  • The history of a centipede sting is usually straightforward. The victim (frequently a gardener) typically sees the creature. Patients may note the following:
    • Severe pain (worse with larger specimens)
    • Local tissue swelling
    • Redness
    • Swollen painful lymph nodes
    • Headache
    • Palpitations
    • Nausea and/or vomiting
    • Anxiety
    • Local pruritus

Physical

  • Local edema
  • Small puncture wounds
  • Erythema
  • Lymphangitis and/or lymphadenopathy
  • Possibility of local necrosis
  • The patient may be noticeably uncomfortable or anxious



[Snake Envenomations, Mojave Rattle]
Abdominal Pain in Elderly Persons
Anaphylaxis
Bee and Hymenoptera Stings
Bites, Insects
Caterpillar Envenomations
Cellulitis
Snake Envenomations, Brown
Snake Envenomations, Cobra
Snake Envenomations, Coral
Snake Envenomations, Moccasins
Snake Envenomations, Rattle
Snake Envenomations, Sea
Spider Envenomations, Brown Recluse
Spider Envenomations, Funnel Web
Spider Envenomations, Redback
Spider Envenomations, Tarantula
Spider Envenomations, Widow


Lab Studies

  • A bedside urine test for proteinuria is reasonable. The same test can detect myoglobinuria secondary to rhabdomyolysis in patients with significant swelling and pain of the affected extremity.
  • If evidence of rhabdomyolysis is present, serum electrolytes, CPK, and renal function studies should be obtained.

Other Tests

  • An ECG should be obtained if the patient has a history of cardiac disease, chest pain, or if there is any evidence of hemodynamic instability following centipede sting.

Procedures

  • If swelling of the affected extremity is severe and a compartment syndrome is suspected, intracompartmental pressures should be objectively assessed.
  • If a compartment syndrome is diagnosed, the limb should be elevated and plans should be made for fasciotomy. A brief trial of intravenous mannitol can be instituted in an effort to reduce pressures before surgery.



Prehospital Care

No specific first aid measures are available for centipede stings. Seek medical care if pain persists or systemic symptoms occur. Local application of ice may reduce some of the discomfort; however, others have anecdotally found that local heat application or immersion in hot (nonscalding) water is more comforting.

Emergency Department Care

  • Management of centipede stings is entirely supportive.
  • Pain may be managed with systemic analgesics, as necessary.
  • Pain may be managed with local injectable anesthetics (eg, lidocaine, bupivacaine). These can be injected locally or used in performing a regional nerve block. A standard text should be consulted regarding techniques of regional anesthesia.
  • Tetanus status should be updated.
  • Prophylactic antibiotics are not necessary, but secondary infections should be cultured and treated with appropriate antibiotics (to cover gram-positive bacteria).
  • Following initial care, examine the wound for any signs of secondary infection or necrosis.
  • Patients should be observed for approximately 4 hours for evidence of systemic toxicity.

Consultations

In the rare case of severe swelling of a stung extremity where a possible developing compartment syndrome is a concern, surgical consultation for compartmental pressure testing should be obtained.



Analgesics and local anesthetics are used to ameliorate the pain associated with these stings. No antivenoms exist for centipede stings.

Drug Category: Analgesics

Pain control is essential to quality patient care. Analgesics ensure patient comfort and have sedating properties, which are beneficial for patients who have sustained centipede envenomations.

Drug NameAcetaminophen (Tylenol, Panadol, Aspirin Free Anacin)
DescriptionDOC to treat pain in patients with documented hypersensitivity to aspirin or NSAIDs, with upper GI disease, or who are taking oral anticoagulants.
Adult Dose325-650 mg PO q4-6h or 1000 mg tid/qid; not to exceed 4 g/d
Pediatric Dose<12 years: 10-15 mg/kg/dose PO q4-6h prn; not to exceed 2.6 g/d
>12 years: 325-650 mg PO q4h; not to exceed 5 doses in 24 h
ContraindicationsDocumented hypersensitivity, known G-6-PD deficiency
InteractionsRifampin can reduce analgesic effects; coadministration of barbiturates, carbamazepine, hydantoins, or isoniazid may increase acetaminophen hepatotoxicity
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsHepatotoxicity possible in chronic alcoholism following various dose levels of acetaminophen; severe or recurrent pain or high or continued fever may indicate serious illness

Drug NameAcetaminophen with codeine (Tylenol #3)
DescriptionIndicated for treatment of mild to moderate pain.
Adult Dose30-60 mg/dose PO (based on codeine content) q4-6h or 1-2 tab PO q4h; not to exceed 12 tab/d
Pediatric Dose0.5-1 mg/kg/dose PO based on codeine content q4-6h; 0-15 mg/kg/dose PO based on acetaminophen content; not to exceed 2.6 g/d acetaminophen
ContraindicationsDocumented hypersensitivity
InteractionsIncreased toxicity when coadministered with CNS depressants or TCAs
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsMay result in acute opiate withdrawal symptoms in patients dependent on opiates; caution in severe renal or hepatic dysfunction

Drug NameAcetaminophen with hydrocodone (Vicodin)
DescriptionIndicated for relief of moderate to severe pain.
Adult Dose1-2 tab or cap PO q4-6h prn pain
Pediatric Dose<12 years: 10-15 mg/kg/dose PO acetaminophen q4-6h prn; not to exceed 2.6 g/d acetaminophen
>12 years: 750 mg acetaminophen PO q4h; not to exceed 10 mg hydrocodone bitartrate per dose; not to exceed 5 doses in 24 h
ContraindicationsDocumented hypersensitivity, patients with high altitude cerebral edema or elevated intracranial pressure
InteractionsToxicity increases when administered concurrently with CNS depressants or TCAs
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsTabs contain metabisulfite, which may cause allergic reactions; upon discontinuation, may result in acute opiate-withdrawal symptoms in patients dependent on opiates; caution in severe renal or hepatic dysfunction

Drug Category: Immunizations

Tetanus immunization should be instituted following a centipede envenomation.

Drug NameDiphtheria-tetanus toxoid (dT)
DescriptionUsed for passive immunization of any person with a wound that may be contaminated with tetanus spores.
Adult DoseProphylaxis: 250-500 U IM in opposite extremity to tetanus toxoid
Clinical tetanus: 3000-10,000 U IM
Pediatric DoseProphylaxis: 250 U IM in opposite extremity as tetanus toxoid
Clinical tetanus: Administer as in adults
ContraindicationsDocumented hypersensitivity; history of any type of neurologic symptoms or signs following administration of this product; FDA recommends that elective tetanus immunization be deferred during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis
InteractionsPatients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization because of poor immune response; cimetidine may enhance or augment delayed-hypersensitivity responses to skin-test antigens; avoid concurrent use of medication with systemic chloramphenicol because it may impair amnestic response to tetanus toxoid; concurrent use of tetanus immune globulin may delay development of active immunity by several days (interaction is nevertheless clinically insignificant and does not preclude concurrent use)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsDo not use to treat actual tetanus infections or for immediate prophylaxis of unimmunized individuals (instead, use tetanus antitoxin, preferably human tetanus immune globulin); diminished antibody response to active immunization may be observed in patients receiving immunosuppressive therapy; better to defer primary diphtheria immunization until immunosuppressive therapy discontinued; routine immunization of symptomatic and asymptomatic HIV-infected persons is recommended
Persons with isolated IgA deficiency have potential for developing antibodies to IgA and could have anaphylactic reactions to subsequent administration of blood products that contain IgA
Do not perform skin testing because intradermal injection of concentrated gamma globulin may cause localized area of inflammation that can be misinterpreted as a positive allergic reaction when it is actually a localized chemical tissue irritation; true allergic responses to human gamma globulin given in the prescribed IM manner are extremely rare; do not admix with other medications (usually incompatible)

Drug Category: Anesthetics

Indicated for pain relief. Stabilize the neuronal membrane and prevent initiation and transmission of nerve impulses, thereby producing local anesthetic action.

Drug NameLidocaine (Xylocaine)
DescriptionInhibits depolarization of type C sensory neurons by blocking sodium channels.
Epinephrine prolongs effect and enhances hemostasis (maximum epinephrine dose 4.5-7 mg/kg).
Adult DosePlain: 4.5 mg/kg injected locally
With epinephrine: 7 mg/kg injected locally
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; avoid in Adams-Stokes syndrome and Wolff-Parkinson-White syndrome; avoid in severe sinoatrial, AV, or intraventricular block if artificial pacemaker not in place
InteractionsCoadministration with cimetidine or beta-blockers increases toxicity of lidocaine; coadministration with procainamide and tocainide may result in additive cardiodepressant action; may increase effects of succinylcholine
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsUse solution without preservatives; caution in heart failure, hepatic disease, hypoxia, hypovolemia or shock, respiratory depression, and bradycardia; may increase risk of CNS and cardiac adverse effects in elderly patients; high plasma concentrations can cause seizures, heart block, and AV conduction abnormalities

Drug NameBupivacaine (Marcaine, Sensorcaine)
DescriptionMay reduce pain by slowing nerve impulse propagation and reducing action potential, which in turn prevents initiation and conduction of nerve impulses.
Epinephrine prolongs effect and enhances hemostasis (maximum epinephrine dose 4.5-7 mg/kg).
Adult DosePlain: 2 mg/kg injected locally
With epinephrine: 3 mg/kg injected locally
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; septicemia; spinal deformities; severe hypertension; existing neurologic disease
InteractionsMay enhance effects of CNS depressants; coadministration may increase toxicity of MAOIs, TCAs, beta-blockers, vasopressors, and phenothiazines
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsTest a dose and monitor for CNS toxicity and cardiovascular toxicity; caution with inflammation or sepsis in region of proposed injection; monitor patient's state of consciousness after each injection; caution in hypertension, cerebral vascular insufficiency, peripheral vascular disease or heart block, and arteriosclerotic heart disease

Drug Category: Nonsteroidal anti-inflammatory drugs (NSAIDs)

NSAIDs are most commonly used to relieve mild to moderate pain. Although effects of NSAIDs in the treatment of pain tend to be patient specific, ibuprofen is usually the DOC for initial therapy. Other options include fenoprofen, flurbiprofen, mefenamic acid, ketoprofen, indomethacin, and piroxicam.

Drug NameIbuprofen (Ibuprin, Advil, Motrin)
DescriptionUsually DOC for treatment of mild to moderate pain if no contraindications exist.
Inhibits inflammatory reactions and pain, probably by decreasing prostaglandin synthesis.
Adult Dose200-400 mg PO q4-6h while symptoms persist; not to exceed 3.2 g/d
Pediatric Dose<6 months: Not established
6 months to 12 years: 20-40 mg/kg/d PO divided tid/qid
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity; avoid in patients with peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding
InteractionsMay decrease effects of loop diuretics when coadministered; concurrent administration with anticoagulants may increase PT (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate toxicity; probenecid may increase toxicity of NSAIDs
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; caution with congestive heart failure, hypertension, and decreased renal and hepatic function

Drug NameKetoprofen (Oruvail, Orudis, Actron)
DescriptionFor relief of mild to moderate pain and inflammation. Small dosages are initially indicated in small or elderly patients and in those with renal or liver disease. Doses >75 mg do not increase therapeutic effects. Administer high doses with caution and closely observe patient for response.
Adult Dose25-50 mg PO q6-8h prn; not to exceed 300 mg/d
Pediatric Dose<3 months: Not established
3 months to 12 years: 0.1-1 mg/kg PO q6-8h
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsMay decrease effects of loop diuretics when coadministered; concurrent administration with anticoagulants may increase PT (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate and phenytoin toxicity; probenecid may increase toxicity of NSAIDs
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; caution in patients with GI disease, cardiovascular disease, renal or hepatic impairment, and in those taking anticoagulants

Drug NameFlurbiprofen (Ansaid)
DescriptionMay inhibit cyclooxygenase, causing inhibition of prostaglandin biosynthesis. These effects may result in analgesic, antipyretic, and anti-inflammatory activities.
Adult Dose200-300 mg/d PO divided bid/qid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsMay decrease effects of loop diuretics when coadministered; concurrent administration with anticoagulants may increase PT (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate and phenytoin toxicity; probenecid may increase toxicity of NSAIDs
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug

Drug NameNaproxen (Anaprox, Naprelan, Naprosyn)
DescriptionFor relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of cyclooxygenase, which results in decrease of prostaglandin synthesis.
Adult Dose500 mg PO; follow with 250 mg q6-8h; not to exceed 1.25 g/d
Pediatric Dose<2 years: Not established
>2 years: 2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d
ContraindicationsDocumented hypersensitivity; avoid in peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding
InteractionsMay decrease effects of loop diuretics when coadministered; concurrent administration with anticoagulants may increase PT (monitor and watch for signs of bleeding); may increase serum lithium levels and risk of methotrexate and phenytoin toxicity; probenecid may increase toxicity of NSAIDs
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of drug

Drug NameMefenamic acid (Ponstel)
DescriptionInhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Adult Dose500 mg PO initially; follow with 250 mg PO q4h prn
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity; peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, and high risk of bleeding
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and possibly toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCategory D in third trimester of pregnancy; may have adverse effects in fetus; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy

Drug NameIndomethacin (Indocin)
DescriptionRapidly absorbed. Metabolism occurs in liver by demethylation, deacetylation, and glucuronide conjugation. Inhibits prostaglandin synthesis.
Adult Dose25-50 mg PO bid/tid
75 mg SR PO bid; not to exceed 200 mg/d
Pediatric Dose1-2 mg/kg/d divided PO bid/qid; not to exceed 4 mg/kg/d or 150-200 mg/d
ContraindicationsDocumented hypersensitivity; GI bleeding or renal insufficiency
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and possibly toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; reversible leukopenia may occur (discontinue if persistent leukopenia, granulocytopenia, or thrombocytopenia)

Drug NamePiroxicam (Feldene)
DescriptionDecreases activity of cyclooxygenase, which, in turn, inhibits prostaglandin synthesis. These effects decrease formation of inflammatory mediators.
Adult Dose10-20 mg/d PO qd
Pediatric Dose0.2-0.3 mg/kg/d PO qd; not to exceed 15 mg/d
ContraindicationsDocumented hypersensitivity; active GI bleeding
InteractionsCoadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; may increase PT when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCategory D in third trimester of pregnancy; acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; reversible leukopenia may occur (discontinue if persistent leukopenia, granulocytopenia, or thrombocytopenia)

Drug Category: Osmotic diuretics

In the setting of documented compartment syndrome, osmotic diuretics such as mannitol may, when combined with elevation of the extremity, obviate the need for fasciotomy if pressures respond rapidly.

Drug NameMannitol (Osmitrol, Resectisol)
DescriptionAn osmotic diuretic. Inhibits tubular reabsorption of electrolytes by increasing osmotic pressure of glomerular filtrate. Increases urinary output.
Adult Dose0.25-0.5 g/kg/dose IV; limit to bid for no more than 2 d to avoid resistance
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity; anuria, severe pulmonary congestion, progressive renal damage, severe dehydration, active intracranial bleeding, and progressive heart failure; hypotension
InteractionsMay decrease serum lithium levels
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCarefully evaluate cardiovascular status before rapid administration of mannitol since a sudden increase in extracellular fluid may lead to fulminating CHF; avoid pseudoagglutination, when blood given simultaneously, add at least 20 mEq of sodium chloride to each liter of mannitol solution; do not give electrolyte-free mannitol solutions with blood



Further Inpatient Care

  • If soft tissue swelling is severe or rhabdomyolysis is evident, the patient should be admitted and observed for development of compartment syndrome and management of myoglobinuria as needed.

Further Outpatient Care

  • Observe patients for evidence of infection or necrosis.
  • Manage local necrosis by sound conservative wound care.

Deterrence/Prevention

  • Never touch or handle centipedes.
  • Use caution when gardening, turning soil, or picking up rocks.
  • Work gloves are very helpful in preventing stings.

Complications

  • Secondary infection
  • Wound necrosis (uncommon)
  • Rare rhabdomyolysis, myoglobinuria, and acute renal failure
  • Possible coronary vasospasm

Prognosis

  • Prognosis is excellent in the vast majority of cases.



Medical/Legal Pitfalls

  • Failure to update the patient's tetanus status when indicated
  • Failure to provide appropriate instructions concerning wound management
  • Failure to arrange follow-up care in the event of a secondary infection
  • Failure to diagnose rhabdomyolysis or compartment syndrome in a victim of severe centipede sting
  • Failure to obtain an ECG in the rare patient with chest pain or hemodynamic instability following centipede sting



Media file 1:  Giant desert centipede. Photo by Michael Cardwell.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Balit CR, Harvey MS, Waldock JM, Isbister GK. Prospective study of centipede bites in Australia. J Toxicol Clin Toxicol. 2004;42(1):41-8. [Medline].
  • Bush SP, King BO, Norris RL, Stockwell SA. Centipede envenomation. Wilderness Environ Med. 2001;12(2):93-9. [Medline].
  • Hare T. Poisonous Dwellers of the Desert. Southwest Parks & Monuments Association;1995:1-32.
  • Hasan S, Hassan K. Proteinuria associated with centipede bite. Pediatr Nephrol. Apr 2005;20(4):550-1. [Medline].
  • Logan JL, Ogden DA. Rhabdomyolysis and acute renal failure following the bite of the giant desert centipede Scolopendra heros. West J Med. Apr 1985;142(4):549-50. [Medline].
  • McFee RB, Caraccio TR, Mofenson HC, McGuigan MA. Envenomation by the Vietnamese centipede in a Long Island pet store. J Toxicol Clin Toxicol. 2002;40(5):573-4. [Medline].
  • Ozsarac M, Karcioglu O, Ayrik C, et al. Acute coronary ischemia following centipede envenomation: case report and review of the literature. Wilderness Environ Med. 2004;15(2):109-12. [Medline].
  • Peters S. A Colour Atlas of Arthropods in Clinical Medicine. Wolfe Pub Ltd;1992:1-304.
  • Yildiz A, Biceroglu S, Yakut N, et al. Acute myocardial infarction in a young man caused by centipede sting. Emerg Med J. Apr 2006;23(4):e30. [Medline].

Centipede Envenomation excerpt

Article Last Updated: Feb 8, 2007